Centre for Advancing Health Outcomes, Providence Research, Vancouver, BC, Canada.
Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
J Headache Pain. 2024 Oct 9;25(1):170. doi: 10.1186/s10194-024-01882-4.
Migraine is a prevalent neurologic disorder that affects women more than men. Examining health-related quality of life (HRQoL) by gender can aid decision makers in prioritizing future treatment and prevention programs. We aimed to quantify HRQoL by different levels of migraine disability and by gender.
As part of a Canada-wide cross-sectional study, we administered an online survey to employed adults who self-reported a diagnosis of migraine. Migraine disability level was assessed using the Migraine Disability Assessment questionnaire (MIDAS). MIDAS scores were used to categorize respondents as having little to no, mild, moderate, or severe level of migraine-related disability. Physical and mental component summary scores (PCS and MCS) and health utilities were derived from responses to the Veterans Rand 12 Item Health Survey. PCS, MCS, and health utilities were summarized by migraine-related disability levels and gender. Covariate-adjusted linear regressions were used to examine the association between migraine disability level and health utility by gender.
A total of 441 participants completed the survey. The sample was predominantly women (60.1%), White race (75.5%), and had a mean age of 37 years. Mean health utility, PCS, and MCS scores were 0.61 (0.22), 45.0 (7.7), and 43.4 (11.0), respectively. All three scores decreased with increased migraine disability level. Gender differences on HRQoL within each migraine disability level were not statistically significant, except in the little to no disability level where women had lower mean MCS scores and health utility relative to men [mean (SD) MCS: women 44.0 (11.3); men 55.1 (8.1), p < 0.001; health utility: women 0.66 (0.18); men 0.81 (0.18), p < 0.001]. Linear regressions showed women with severe migraine-related disability had reduced health utility compared to women with little to no disability [adjusted difference: -0.16 (95%CI -0.24,-0.09)]. Associations among men increased in magnitude with migraine disability level [adjusted differences: mild - 0.16 (95%CI -0.24,-0.09); moderate - 0.18 (95%CI -0.26,-0.10); severe - 0.28 (95%CI -0.37,-0.20)].
Findings contribute to the literature on the association between migraine disability level and HRQoL by examining trends by gender. Model results emphasize the importance of future treatments reducing severe disability due to migraine among both women and men.
偏头痛是一种常见的神经系统疾病,女性患者多于男性。通过性别分析健康相关生活质量(HRQoL),有助于决策者为未来的治疗和预防计划确定优先事项。我们旨在根据偏头痛的不同残疾程度和性别来量化 HRQoL。
作为一项加拿大全国性横断面研究的一部分,我们向自我报告偏头痛诊断的在职成年人发放了在线调查问卷。使用偏头痛残疾评估问卷(MIDAS)评估偏头痛残疾程度。MIDAS 评分用于将受访者分为无或轻度、中度、重度偏头痛相关残疾。身体和精神成分综合评分(PCS 和 MCS)和健康效用来自退伍军人兰德 12 项健康调查的回答。根据偏头痛相关残疾程度和性别总结 PCS、MCS 和健康效用。使用协变量调整的线性回归分析性别与偏头痛残疾程度与健康效用之间的关系。
共有 441 名参与者完成了调查。样本主要为女性(60.1%)、白种人(75.5%),平均年龄为 37 岁。平均健康效用、PCS 和 MCS 评分为 0.61(0.22)、45.0(7.7)和 43.4(11.0)。所有三项评分均随偏头痛残疾程度的增加而降低。除在无或轻度残疾水平,女性的 MCS 评分和健康效用低于男性外,在每个偏头痛残疾水平的 HRQoL 方面,性别差异无统计学意义[平均(SD)MCS:女性 44.0(11.3);男性 55.1(8.1),p<0.001;健康效用:女性 0.66(0.18);男性 0.81(0.18),p<0.001]。线性回归显示,与无或轻度偏头痛相关残疾的女性相比,严重偏头痛相关残疾的女性健康效用降低[调整差异:-0.16(95%CI -0.24,-0.09)]。与男性相关的关联随着偏头痛残疾程度的增加而增加[调整差异:轻度-0.16(95%CI -0.24,-0.09);中度-0.18(95%CI -0.26,-0.10);重度-0.28(95%CI -0.37,-0.20)]。
这些发现通过研究性别趋势,为偏头痛残疾程度与 HRQoL 之间的关联提供了文献依据。模型结果强调了未来治疗的重要性,需要减少女性和男性因偏头痛导致的严重残疾。